Abstract:In the author's institution, 2254 patients with hepatocellular carcinoma (HCC) have been treated during 1958-1994. The overall 5-year survival increased from 5.4% (1958-1970), to 11.9% (1971-1982), to 46.2% (1983-1984), which correlated well with the increasing proportion of small HCC in the series (2.6%, 12.1%, and 33.4%, respectively); with the increasing percentage of limited resection (3.1%, 32.2%, and 58.3%); with the increasing number of re-resections for recurrence (0, 27, and 114 patients); and with the increasing number of second stage resections (0, 5, and 67 patients). In our institution, surgical approaches that resulted in significantly prolonging survival included: small HCC resection, re-resection, and cytoreduction followed by sequential resection for initially unresectable HCC. Experience in these 3 aspects suggests: (a) Small HCCs are mainly found by screening using AFP and ultrasonography (US) in a high risk population, and limited resection is the best treatment in patients with compensated liver cirrhosis, the 5-year survival after resection being 62.9% (n = 549). (b) Postoperative monitoring using AFP/US every 2-3 months for 5-10 years after curative resection is needed to detect subclinical recurrence. Limited re-resection is indicated for liver recurrence less than 3 nodules, and lung lobectomy is of proven merit to prolong survival for solitary lung metastasis. Re-resection of subclinical recurrence has resulted in a 10-20% further increase in 5-year survival after curative resection. (c) Palliative surgery other than resection such as hepatic artery ligation (HAL) and cannulation with arterial infusion (HAI), cryosurgery, etc. are superior to palliative resection with residual cancer. (d) Cytoreduction and sequential resection have provided hope for localized unresectable HCC, particularly in the right cirrhotic liver. Multimodality combination treatments such as HAL+HAI+radioimmunotherapy/regional radiotherapy are acceptable cytoreductive therapies. Repeated transcatheter hepatic arterial chemoembolization (TACE) is an alternative nonsurgical approach. Sequential resection is important to eradicate residual cancer after cytoreduction. The 5-year survival of 72 patients with cytoreduction and sequential resection for initially unresectable HCC was 62.1% and resulted in improving 5-year survival in the entire series of unresectable HCC over the 3 periods from 0% to 7.4% to 25.7%, respectively. However, multicentric origin and tumor invasiveness are two major targets to be studied in the control of recurrence and metastasis.

Clinical Analysis of 57 Patients with Advanced HCC Survived over Two Years

Hepatocellular Carcinoma: Clinical Study of Long-Term Survival and Choice of Treatment Modalities

Clinical Features of Long-Term Survivors (LTS) of Advanced Hepatocellular Carcinoma Undergoing Molecular Targeted Therapy (MTT).

Systemic Chemotherapy Improves Outcome of Hepatocellular Carcinoma Patients Treated with Transarterial Chemoembolization

Transarterial Chemoembolization Related to Good Survival for Selected Patients with Advanced Hepatocellular Carcinoma

[Prognostic Factors Influencing Survival in Patients with Large Hepatocellular Carcinoma Receiving Combined Transcatheter Arterial Chemoembolization and Radiotherapy].

Long-term survival after liver transplantation in hepatocellular carcinoma patients: a single-center experience

A retrospective analysis of treatment of 113 patients with multiple hepatocellular carcinoma

Survival Analysis of 53 Patients with Hepatocellular Carcinoma Undergoing Adjuvant Transcatheter Arterial Chemoembolization after Radical Resection

An Approach Improving Long-Term Outcome of Surgery for Hepatocellular Carcinoma: Analysis of 113 Patients Surviving More Than Five Years

Sequential Transcatheter Arterial Chemoembolization, Three-Dimensional Conformal Radiotherapy, and High-Intensity Focused Ultrasound Treatment for Unresectable Hepatocellular Carcinoma Patients

Therapeutic analysis of 632 cases treated by transcatheter arterial chemoembolization combined with ablation in hepatocellular carcinoma: A retrospective study

Three Decades' Experience In Surgery Of Hepatocellular Carcinoma

A Retrospective Study on Two Surgical Techniques in the Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus and to Determine the Prognostic Factors of Overall Survival

Influence of Antiviral Therapy on Survival of Patients with Hepatitis B-Associated Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization

Long-term prognosis in hepatocellular carcinoma patients after hepatectomy.

A retrospective analysis on survival factors of transarterial chemoembolization for patients of pancreatic carcinoma with liver metastasis

Hepatocellular Carcinoma in a Large Medical Center of China over a 10-Year Period: Evolving Therapeutic Option and Improving Survival.

Clinical strategies of multidisciplinary interventional treatment for advanced liver cancer

Surgical Treatment of Primary Hepatoeellular Carcinoma: a 20-Year Clinical Experience in 7566 Patients

The study of treatment for hepatocellular carcinoma with decompensate cirrhosis by multi-interventional modes